BG104873A - New substituted amides, their production and their use - Google Patents
New substituted amides, their production and their useInfo
- Publication number
- BG104873A BG104873A BG104873A BG10487300A BG104873A BG 104873 A BG104873 A BG 104873A BG 104873 A BG104873 A BG 104873A BG 10487300 A BG10487300 A BG 10487300A BG 104873 A BG104873 A BG 104873A
- Authority
- BG
- Bulgaria
- Prior art keywords
- alkyl
- production
- phenyl
- ring
- substituted amides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/36—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to an acyclic carbon atom of a hydrocarbon radical substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Polyamides (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19818615 | 1998-04-20 | ||
PCT/EP1999/002633 WO1999054310A2 (fr) | 1998-04-20 | 1999-04-20 | Inhibiteurs de protease de cysteine |
Publications (1)
Publication Number | Publication Date |
---|---|
BG104873A true BG104873A (en) | 2001-07-31 |
Family
ID=7865831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG104873A BG104873A (en) | 1998-04-20 | 2000-10-17 | New substituted amides, their production and their use |
Country Status (22)
Country | Link |
---|---|
US (4) | US6753327B1 (fr) |
EP (1) | EP1073641B1 (fr) |
JP (1) | JP4782924B2 (fr) |
KR (1) | KR20010042840A (fr) |
CN (1) | CN1306505A (fr) |
AT (1) | ATE264310T1 (fr) |
AU (1) | AU3927699A (fr) |
BG (1) | BG104873A (fr) |
BR (1) | BR9909774A (fr) |
CA (1) | CA2328396C (fr) |
DE (1) | DE59909183D1 (fr) |
ES (1) | ES2220061T3 (fr) |
HR (1) | HRP20000787A2 (fr) |
HU (1) | HUP0102732A3 (fr) |
ID (1) | ID26403A (fr) |
IL (1) | IL138703A0 (fr) |
NO (1) | NO20005263D0 (fr) |
PL (1) | PL343896A1 (fr) |
SK (1) | SK14512000A3 (fr) |
TR (1) | TR200003068T2 (fr) |
WO (1) | WO1999054310A2 (fr) |
ZA (1) | ZA200006719B (fr) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19817459A1 (de) * | 1998-04-20 | 1999-10-21 | Basf Ag | Neue heterozyklische substituierte Amide, Herstellung und Anwendung |
EP1073641B1 (fr) | 1998-04-20 | 2004-04-14 | Abbott GmbH & Co. KG | Inhibiteurs de protease de cysteine |
ATE344794T1 (de) * | 1998-05-25 | 2006-11-15 | Abbott Gmbh & Co Kg | Heterocyclische substituierte amide, deren herstellung und verwendung |
DE10114762A1 (de) * | 2001-03-26 | 2002-10-02 | Knoll Gmbh | Verwendung von Cysteinprotease-Inhibitoren |
SE0102299D0 (sv) | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
EP1465862A1 (fr) | 2002-01-17 | 2004-10-13 | SmithKline Beecham Corporation | Derives de cetoamides a substitution cycloalkyle, utiles comme inhibiteurs de cathepsine k |
AU2003291308B2 (en) | 2002-11-12 | 2009-06-18 | Merck & Co., Inc. | Phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer's disease |
RU2423353C1 (ru) | 2002-12-20 | 2011-07-10 | Глэксо Груп Лимитед | Новые производные бензазепина |
US20040204422A1 (en) | 2003-04-14 | 2004-10-14 | Abbott Gmbh & Co. Kg. | N-[(Piperazinyl)hetaryl]arylsulfonamide compounds |
ES2536626T3 (es) | 2006-12-29 | 2015-05-27 | Abbvie Deutschland Gmbh & Co Kg | Compuestos de carboxamida y su uso como inhibidores de calpaína |
TWI453019B (zh) | 2007-12-28 | 2014-09-21 | Abbvie Deutschland | 甲醯胺化合物 |
US20100192866A1 (en) * | 2009-02-03 | 2010-08-05 | Mcmullen Joseph E | Disposable hummingbird feeder |
TWI519530B (zh) | 2009-02-20 | 2016-02-01 | 艾伯維德國有限及兩合公司 | 羰醯胺化合物及其作為鈣蛋白酶(calpain)抑制劑之用途 |
US8236798B2 (en) | 2009-05-07 | 2012-08-07 | Abbott Gmbh & Co. Kg | Carboxamide compounds and their use as calpain inhibitors |
US9051304B2 (en) | 2009-12-22 | 2015-06-09 | AbbVie Deutschland GmbH & Co. KG | Carboxamide compounds and their use as calpain inhibitors V |
US8598211B2 (en) | 2009-12-22 | 2013-12-03 | Abbvie Inc. | Carboxamide compounds and their use as calpain inhibitors IV |
CN103599588B (zh) | 2010-04-30 | 2017-04-26 | 雅培心脏血管系统股份有限公司 | 呈现迅速膨胀和收缩的改进型球囊导管 |
WO2012076639A1 (fr) | 2010-12-09 | 2012-06-14 | Abbott Gmbh & Co. Kg | Composés de carboxamide et leur utilisation comme inhibiteurs v de la calpaïne |
EP2834230A1 (fr) | 2012-04-03 | 2015-02-11 | AbbVie Deutschland GmbH & Co KG | Composés carboxamides et leur utilisation comme inhibiteurs de calpaïne v |
US9013997B2 (en) | 2012-06-01 | 2015-04-21 | Broadcom Corporation | System for performing distributed data cut-through |
WO2017156071A1 (fr) | 2016-03-09 | 2017-09-14 | Blade Therapeutics, Inc. | Composés céto-amides cycliques utilisés en tant que modulateurs de la calpaïne, et leurs procédés de production et d'utilisation |
WO2018009417A1 (fr) | 2016-07-05 | 2018-01-11 | Blade Therapeutics, Inc. | Modulateurs de calpain et leurs utilisations thérapeutiques |
KR20190063473A (ko) | 2016-09-28 | 2019-06-07 | 블레이드 테라퓨틱스, 인크. | 칼페인 조정자 및 그 치료학적 용도 |
WO2024018245A1 (fr) * | 2022-07-22 | 2024-01-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Utilisation d'inhibiteurs de calpaïne pour le traitement de la maladie rénale diabétique |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992012140A1 (fr) | 1990-12-28 | 1992-07-23 | Georgia Tech Research Corporation | Cetoamides, cetoacides et cetoesters peptidiques |
CA2098609A1 (fr) | 1990-12-28 | 1992-06-29 | Raymond T. Bartus | Utilisation d'inhibiteurs de la calpaine dans l'inhibition et le traitement de la neurodegenerescence |
EP0579724B2 (fr) | 1991-04-10 | 2010-04-28 | Mayo Foundation For Medical Education And Research | Systeme d'imagerie a foyer commun pour la lumiere visible et la lumiere ultraviolette |
CA2071621C (fr) | 1991-06-19 | 1996-08-06 | Ahihiko Hosoda | Derives d'aldehyde |
EP0650368A1 (fr) | 1992-06-24 | 1995-05-03 | Cortex Pharmaceuticals, Inc. | Emploi d'inhibiteurs de calpaine dans l'inhibition et le traitement d'etats medicaux associes a une activite de calpaine accrue |
US5541290A (en) | 1993-06-24 | 1996-07-30 | Harbeson; Scott L. | Optically pure calpain inhibitor compounds |
JP3216458B2 (ja) | 1994-12-28 | 2001-10-09 | 富士レビオ株式会社 | アミド誘導体 |
DE19642591A1 (de) * | 1996-10-15 | 1998-04-16 | Basf Ag | Neue Piperidin-Ketocarbonsäure-Derivate, deren Herstellung und Anwendung |
EP1073641B1 (fr) | 1998-04-20 | 2004-04-14 | Abbott GmbH & Co. KG | Inhibiteurs de protease de cysteine |
DE19817459A1 (de) * | 1998-04-20 | 1999-10-21 | Basf Ag | Neue heterozyklische substituierte Amide, Herstellung und Anwendung |
ATE344794T1 (de) * | 1998-05-25 | 2006-11-15 | Abbott Gmbh & Co Kg | Heterocyclische substituierte amide, deren herstellung und verwendung |
-
1999
- 1999-04-20 EP EP99922108A patent/EP1073641B1/fr not_active Expired - Lifetime
- 1999-04-20 CA CA002328396A patent/CA2328396C/fr not_active Expired - Fee Related
- 1999-04-20 AT AT99922108T patent/ATE264310T1/de not_active IP Right Cessation
- 1999-04-20 IL IL13870399A patent/IL138703A0/xx unknown
- 1999-04-20 CN CN99807639A patent/CN1306505A/zh active Pending
- 1999-04-20 ID IDW20002132A patent/ID26403A/id unknown
- 1999-04-20 BR BR9909774-5A patent/BR9909774A/pt not_active IP Right Cessation
- 1999-04-20 JP JP2000544649A patent/JP4782924B2/ja not_active Expired - Fee Related
- 1999-04-20 SK SK1451-2000A patent/SK14512000A3/sk unknown
- 1999-04-20 HU HU0102732A patent/HUP0102732A3/hu unknown
- 1999-04-20 PL PL99343896A patent/PL343896A1/xx unknown
- 1999-04-20 US US09/673,089 patent/US6753327B1/en not_active Expired - Fee Related
- 1999-04-20 WO PCT/EP1999/002633 patent/WO1999054310A2/fr not_active Application Discontinuation
- 1999-04-20 AU AU39276/99A patent/AU3927699A/en not_active Abandoned
- 1999-04-20 DE DE59909183T patent/DE59909183D1/de not_active Expired - Lifetime
- 1999-04-20 KR KR1020007011607A patent/KR20010042840A/ko not_active Application Discontinuation
- 1999-04-20 TR TR2000/03068T patent/TR200003068T2/xx unknown
- 1999-04-20 ES ES99922108T patent/ES2220061T3/es not_active Expired - Lifetime
-
2000
- 2000-10-17 BG BG104873A patent/BG104873A/xx unknown
- 2000-10-19 NO NO20005263A patent/NO20005263D0/no not_active Application Discontinuation
- 2000-11-17 ZA ZA200006719A patent/ZA200006719B/xx unknown
- 2000-11-17 HR HR20000787A patent/HRP20000787A2/hr not_active Application Discontinuation
-
2003
- 2003-10-20 US US10/690,400 patent/US7276500B2/en not_active Expired - Fee Related
-
2007
- 2007-08-29 US US11/897,057 patent/US7956093B2/en not_active Expired - Fee Related
-
2010
- 2010-10-29 US US12/915,680 patent/US20110275615A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US7956093B2 (en) | 2011-06-07 |
KR20010042840A (ko) | 2001-05-25 |
ID26403A (id) | 2000-12-21 |
JP4782924B2 (ja) | 2011-09-28 |
US20110275615A1 (en) | 2011-11-10 |
ZA200006719B (en) | 2002-08-15 |
CA2328396C (fr) | 2009-02-10 |
AU3927699A (en) | 1999-11-08 |
EP1073641A2 (fr) | 2001-02-07 |
BR9909774A (pt) | 2000-12-19 |
JP2002512231A (ja) | 2002-04-23 |
US6753327B1 (en) | 2004-06-22 |
WO1999054310A2 (fr) | 1999-10-28 |
HUP0102732A2 (hu) | 2001-12-28 |
EP1073641B1 (fr) | 2004-04-14 |
CA2328396A1 (fr) | 1999-10-28 |
HRP20000787A2 (en) | 2001-08-31 |
US7276500B2 (en) | 2007-10-02 |
IL138703A0 (en) | 2001-10-31 |
US20040082569A1 (en) | 2004-04-29 |
HUP0102732A3 (en) | 2002-12-28 |
SK14512000A3 (sk) | 2001-04-09 |
TR200003068T2 (tr) | 2001-03-21 |
ATE264310T1 (de) | 2004-04-15 |
DE59909183D1 (de) | 2004-05-19 |
US20080113989A1 (en) | 2008-05-15 |
CN1306505A (zh) | 2001-08-01 |
PL343896A1 (en) | 2001-09-10 |
WO1999054310A3 (fr) | 2000-02-17 |
NO20005263L (no) | 2000-10-19 |
ES2220061T3 (es) | 2004-12-01 |
NO20005263D0 (no) | 2000-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG104873A (en) | New substituted amides, their production and their use | |
AR031627A1 (es) | Activadores heteroaromaticos fusionados de la glucoquinasa | |
HUP0101624A2 (hu) | Új szubsztituált amidok, előállításuk és alkalmazásuk | |
EA200300777A1 (ru) | N-фенпропилциклопентил-замещенные производные глутарамида в качестве nep ингибиторов для fsad | |
HUP0003303A2 (hu) | 3-Aminopiridin-származékot tartalmazó keratinszálak oxidációs festésére alkalmas készítmény és festési eljárás a készítmény alkalmazásával | |
ATE417038T1 (de) | Phenylpyridincarbonyl piperazinderivate | |
BG104842A (en) | New hydroxyindoles, their use as phosphodiesterase 4 inhibitiors and methods for producing same | |
HUP9801711A2 (hu) | Helyettesített imidazolidin-2,4-dion-vegyületek felhasználása fájdalomcsillapító szerként alkalmazható gyógyszerkészítmények előállítására | |
MY130697A (en) | 4-trifluoromethylpyrazolyl-substituted pyridines and pyrimidines | |
NZ337531A (en) | Substituted benzamides as immunomodulator for normalisation of IL-10/IL/12 balance | |
DK249089A (da) | Benzamid-forbindelser, der er nyttige som protease-inhibitorer | |
MXPA01004854A (es) | Nuevos compuestos de piperazina y piperidina. | |
AR026351A1 (es) | Derivados de pirrol como inhibidores de la fosfodiesterasa vii | |
WO2000005223A3 (fr) | Composes chimiques | |
AP2001002265A0 (en) | Phenoxybenzylamine derivatives as SSRIs. | |
DE59906365D1 (de) | Benzamide mit tetrahydrofuranyloxy-substituenten als inhibitoren der phosphodiesterase 4 | |
EA200200558A1 (ru) | 2-( 1h-индол-3-ил)-2-оксоацетамиды, обладающие противоопухолевой активностью | |
NO964698D0 (no) | Bicykliske aminderivater som inhibitorer av nitrogenoksid-syntetase | |
DK0677042T3 (da) | Selektive ligander af 5HT1D-5HT1B-receptorer, der er afledt af indolpiperazin og er nyttige som lægemidler | |
RS50772B (sr) | Pentafluorsulfanil-benzoilgvandini, postupak za njihovu proizvodnju, njihova primena u svojstvu leka ili dijagnostičkog sredstva kao i lek koji sadrži ova jedinjenja | |
CO5160261A1 (es) | Derivados de bifenilo sustituidos que son antagonistas nk-1, su procedimiento de sintesis y composiciones farmaceuticas que los contienen | |
RS49888B (sr) | Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin-10-oli, postupak za njihovo pripremanje i njihova primena kao lekova | |
SE8203877L (sv) | Aminosulfonylbensoesyraderivat | |
HRP20020440B1 (en) | 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof | |
CO5040091A1 (es) | Derivados de urea |